Schedule 13G ownership disclosure
Bicara Therapeutics Inc
COMMON STOCK · CUSIP: 055477103
Event date: 2025-07-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 2,756,217.00 · Class: 5.1%
- Abigail P. Johnson
Shares: 2,756,217.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-001693
- Form type
- SCHEDULE 13G
- Filer
- Bicara Therapeutics Inc.
- CIK
- CIK 2023658
- Filed
- Jul 17, 2025
- Reporting period
- Jul 10, 2025
- Description
- Schedule 13G beneficial ownership